Abstract:A structure-function analysis of the influenza A virus M2 ion channel protein was performed. The M2 protein of human influenza virus A/Udorn/72 and mutants containing changes on one face of the putative alpha helix of the M2 transmembrane (TM) domain, several of which lead to amantadine resistance when found in virus, were expressed in oocytes of Xenopus laevis. The membrane currents of oocytes expressing mutant M2 ion channels were measured at both normal and low pH, and the amantadine-resistant mutant containing the change of alanine at residue 30 to threonine was found to have a significantly attenuated low pH activation response. The specific activity of the channel current of the amantadine-resistant mutants was investigated by measuring the membrane current of individual oocytes followed by quantification of the amount of M2 protein expressed in these single oocytes by immunoblotting analysis. The data indicate that changing residues on this face of the putative alpha helix of the M2 TM domain alters properties of the M2 ion channel. Some of the M2 proteins containing changes in the TM domain were found to be modified by addition of an N-linked carbohydrate chain at an asparagine residue that is membrane proximal and which is not modified in the wild-type M2 protein. These N-linked carbohydrate chains were further modified by addition of polylactosaminoglycan. A glycosylated M2 mutant protein (M2 + V, A30T) exhibited an ion channel activity with a voltage-activated, time-dependent kinetic component. Prevention of carbohydrate addition did not affect the altered channel activity. The ability of the M2 protein to tolerate deletions in the TM domain was examined by expressing three mutants (del29-31, del28-31, and del27-31) containing deletions of three, four, and five residues in the TM domain. No ion channel activity was detected from expression of M2 del29-31 and del27-31, whereas expression of M2 del28-31 resulted in an ion channel activity that was activated by hyperpolarization (and not low pH) and was resistant to amantadine block. Examination of the oligomeric form of M2 del28-31 indicated that the oligomer is different from wild-type M2, and the data were consistent with M2 del28-31 forming a pentamer.

Recent advances in computational studies on influenza a virus M2 proton channel.

Drug inhibition and proton conduction mechanisms of the influenza a M2 proton channel.

Structure and function of the influenza A M2 proton channel.

Structural comparison of the wild-type and drug-resistant mutants of the influenza A M2 proton channel by molecular dynamics simulations.

Structural Basis for Interactions between Influenza A Virus M2 Proton Channel and Adamantane-Based Antiviral Drugs

Research/review: Structure and linkage disequilibrium analysis of adamantane resistant mutations in influenza virus m2 proton channel.

Insights from studying the mutation-induced allostery in the M2 proton channel by molecular dynamics.

Insights from Investigating the Interactions of Adamantane-Based Drugs with the M2 Proton Channel from the H1N1 Swine Virus

Mechanism of drug inhibition and drug resistance of influenza A M2 channel

The Open-Close Mechanism of M2 Channel Protein in Influenza A Virus: A Computational Study on the Hydrogen Bonds and Cation-Π Interactions among His37 and Trp41

Tackling influenza a virus by M2 ion channel blockers: Latest progress and limitations

Influenza A virus M2 ion channel protein: a structure-function analysis

Insight into the Mechanism of the Influenza A Proton Channel from a Structure in a Lipid Bilayer

Molecular dynamics simulation directed rational design of inhibitors targeting drug-resistant mutants of influenza A virus M2.

Structural and Energetic Analysis of Drug Inhibition of the Influenza A M2 Proton Channel

Activation of the influenza B M2 proton channel (BM2)

Mechanism of Proton Transport of the M2 Proton Channel Studied by Constant Ph Molecular Dynamics

Mapping Water Density To Design New Blockers Against A Viral Proton Channel

Mechanisms of Proton Conduction and Gating in Influenza M2 Proton Channels from Solid-State NMR.

Structures of Two Coronavirus Main Proteases: Implications for Substrate Binding and Antiviral Drug Design.

New Strategy for High Throughput Screening of Anti-Influenza Virus M2 Ion Channel Inhibitors.